Zynex Corp (ZYXI): Enterprise Value to EBITDA Ratio
Zynex, Inc. (ZYXI) has created a comprehensive environment for home-based pain management using electrical stimulation. This chart confirms a market EV/EBITDA valuation of 0.00, which correlates with the maturity of a business expanding its reach in the home medical device segment to combat opioids. The brand's high authority among medical professionals is driven by the safety of NexWave systems, which provide effective relief from chronic suffering without medication.
Comprehensive metric breakdowns and analytics for Zynex Medical (ZYXI)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
ZYXI - Net Financial Result|Projected Future Earnings Zynex, Inc.|ZYXI - Price to Earnings Ratio|Forward P/E Multiple zynex.com|ZYXI - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex Medical|ZYXI - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Zynex|ZYXI - Earnings per share for the trailing year|Quarterly EPS earnings growth zynex.com|ZYXI - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Zynex, Inc.
- sales volume and revenue indicators:
Analysis of all company metrics:Zynex Medical ZYXI
This indicator compares enterprise value (EV) with earnings before interest, taxes, depreciation, and amortization (EBITDA) to determine the extent of the company's overvaluation relative to its ability to generate cash flow. By analyzing the EV/EBITDA ratio chart against historical data on GURU.Markets, a Zynex, Inc. (ZYXI) investor can assess whether the high margins of cyclical consumables sales justify the current market capitalization given the debt load.
Competitor analysis
Dexcom CGM - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PEN (Penumbra, Inc.)|NOVT: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Haemonetics HAE|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (conmed.com) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Biosciences (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode)|Enterprise Value to EBITDA Ratio Picard Medical PMI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics Inc. SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Inc - EV/EBITDA Multiple|Company Value to EBITDA tactilemedical.com|SNWV: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Outset Medical|ELMD (Electromed) - EV/EBITDA Multiple|LENSAR, Inc (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio Profound Medical PROF|EV/EBITDA Multiple BDMD (Baird Medical Investment Holdings)|EV/EBITDA Multiple EDAP TMS S.A. EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (Pulmonx Corp.) - Enterprise Value to EBITDA Ratio|TELA Bio Inc. - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA Sensus Healthcare Inc SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore (ECOR)|Vicarious Surgical Corp (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies Oxy B.H.N. Ltd. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio seastarmedical.com (ICU)|IRIDEX Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions Inc. INBS|Beyond Air (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa, Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization strataskinsciences.com|Enterprise Value to EBITDA Ratio GlucoTrack, Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis, Inc. NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cutera, Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization knowlabs.co|Enterprise Value to Operating Income Before Depreciation NARI (Inari)|Enterprise Value to EBITDA Ratio NVRO (Nevro Corp.)|Total Company Value to Operating Income Before Depreciation Ratio ReShape Lifesciences Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization silkroadmed.com SILK
